Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
08/27/2014 | EP2769992A2 High affinity human antibodies to human IL-4 receptor |
08/27/2014 | EP2769991A1 Antibody targeting through a modular recognition domain |
08/27/2014 | EP2769990A2 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
08/27/2014 | EP2769989A1 Recombinant bispecific antibody that binds to the CD133 antigen on tumor cells and to the human CD3 T cell receptor |
08/27/2014 | EP2769988A1 Anti-gap43 antibody |
08/27/2014 | EP2769987A1 Immunoassay for detecting kratom its constituents and their use |
08/27/2014 | EP2769737A1 Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases |
08/27/2014 | EP2769711A1 Methods and Compositions for Enhanced Delivery of Macromolecules |
08/27/2014 | EP2769220A1 Biomarker |
08/27/2014 | EP2768863A1 Anti-cd22 chimeric antigen receptors |
08/27/2014 | EP2768862A2 Modulation of macrophage activation |
08/27/2014 | EP2768861A1 A m-dc8+ monocyte depleting agent for the prevention or the treatment of a condition associated with a chronic hyperactivation of the immune system |
08/27/2014 | EP2768860A1 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates |
08/27/2014 | EP2768859A1 Antagonists of il17c for the treatment of inflammatory disorders |
08/27/2014 | EP2768858A2 Antibodies directed against influenza |
08/27/2014 | EP2768857A2 Methods of purifying antibodies |
08/27/2014 | EP2768856A1 Peg conjugates of exenatide |
08/27/2014 | EP2768855A2 Stable multiple antigen-binding antibody |
08/27/2014 | EP2768851A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
08/27/2014 | EP2768845A1 Separation method for fucosylated antibodies |
08/26/2014 | US8816057 T1R taste receptors and genes encoding same |
08/26/2014 | US8816055 Plasma kallikrein binding proteins |
08/26/2014 | US8815913 Metal-catalyzed copolymerization of imines and carbon monoxide as a route to synthesize polypeptides |
08/26/2014 | US8815823 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
08/26/2014 | US8815813 Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome |
08/26/2014 | US8815808 Modulation of activity of neurotrophins |
08/26/2014 | US8815550 Targeted perhydrolases |
08/26/2014 | US8815525 Binding and functional assays that use the T1R3 receptor to screen for taste modulatory compounds |
08/26/2014 | US8815250 Clotting factor-Fc chimeric proteins to treat hemophilia |
08/26/2014 | US8815246 Fc receptor binding proteins |
08/26/2014 | US8815245 Method of treating viral diseases |
08/26/2014 | US8815244 Method for production of antibody using ostrich |
08/26/2014 | US8815243 Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing |
08/26/2014 | US8815242 Avian derived antibodies |
08/26/2014 | US8815240 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
08/26/2014 | US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins |
08/26/2014 | US8815236 Method for treating multiple sclerosis and crohn's disease |
08/26/2014 | US8815214 Fluorescent imaging agents |
08/26/2014 | US8815211 Radioactive metal-labeled anti-cadherin antibody |
08/26/2014 | CA2530797C Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
08/26/2014 | CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
08/26/2014 | CA2390344C 85kda neisserial antigen |
08/21/2014 | WO2014127342A1 Peptide additives for enhancing acceptance and ingestion of edibles by rodents and uses thereof |
08/21/2014 | WO2014127261A1 Chimeric antigen receptor and methods of use thereof |
08/21/2014 | WO2014127220A1 Antigen-specific t cell redirectors |
08/21/2014 | WO2014127211A1 Deimmunized gelonin molecules and therapies |
08/21/2014 | WO2014126921A1 Monoclonal antibodies that neutralize norovirus |
08/21/2014 | WO2014126871A1 Tangential flow filtration based protein refolding methods |
08/21/2014 | WO2014125382A2 Cetuximab with modified glycosylation and uses thereof |
08/21/2014 | WO2014125273A1 Therapeutic and diagnostic target for cancer comprising dll3 binding reagents |
08/21/2014 | WO2014125041A1 Treatment of peripheral t cell lymphoma |
08/21/2014 | WO2014124677A1 Acceptor framework for cdr grafting |
08/21/2014 | WO2014100760A3 Antibodies for modulating binding between lrp and wise |
08/21/2014 | WO2014100600A3 Human anti-tau antibodies |
08/21/2014 | WO2014089209A3 Blood-brain barrier (bbb) penetrating dual specific binding proteins |
08/21/2014 | WO2014062659A4 Methods of treating ocular diseases |
08/21/2014 | US20140237632 Rapidly maturing fluroscent proteins and methods for using the same |
08/21/2014 | US20140235843 Antibodies to cd70 |
08/21/2014 | US20140235835 Calicheamicin derivative-carrier conjugates |
08/21/2014 | US20140235833 Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same |
08/21/2014 | US20140235832 Rank ligand polypeptides |
08/21/2014 | US20140235831 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
08/21/2014 | US20140235830 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
08/21/2014 | US20140235829 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha |
08/21/2014 | US20140235828 Gram-positive bacteria specific binding compounds |
08/21/2014 | US20140235827 Mouse anti-aggrus monoclonal antibodies |
08/21/2014 | US20140235476 Multivalent binding protein compositions and methods for identifying variants of same |
08/21/2014 | US20140235473 Diagnosis and/or Prognosis of Parkinson's Disease Dementia |
08/21/2014 | US20140235467 Protease-Resistant Systems for Polypeptide Display and Methods of Making and Using Thereof |
08/21/2014 | US20140234905 Cell culture improvements |
08/21/2014 | US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues |
08/21/2014 | US20140234901 Method for Secretory Production of Protein |
08/21/2014 | US20140234893 Heterologous intron within an immunoglobulin domain |
08/21/2014 | US20140234885 Methods for optimizing domain stability of binding proteins |
08/21/2014 | US20140234878 Composition for diagnosing acute myocardial infarction, kit for diagnosing acute myocardial infarction comprising same, and method of diagnosing acute myocardial infarction |
08/21/2014 | US20140234872 Target of the phosphoinositide 3-kinase pathway |
08/21/2014 | US20140234867 Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof |
08/21/2014 | US20140234364 Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis |
08/21/2014 | US20140234363 Polypeptides from non-typeable haemophilus influenzae |
08/21/2014 | US20140234355 Infectious clones of torque teno virus |
08/21/2014 | US20140234344 Anti-cd40 antibodies and uses thereof |
08/21/2014 | US20140234343 Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin synthesis or release of mononuclear phagocyte system cells as active ingredient |
08/21/2014 | US20140234342 Nkp46-mediated nk cell tuning |
08/21/2014 | US20140234340 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
08/21/2014 | US20140234339 Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site |
08/21/2014 | US20140234338 Therapeutic agent for use in a method of treating psoriasis or atopic dermatitis |
08/21/2014 | US20140234337 Antibody and antibody-containing composition |
08/21/2014 | US20140234336 Binding Molecule Having Influenza A Virus-Neutralizing Activity Produced from Human B Cell |
08/21/2014 | US20140234335 Method and reagent for diagnosis and/or evaulation of progression of graft-versus-host disease |
08/21/2014 | US20140234334 Peptides and related molecules that bind to tall-1 |
08/21/2014 | US20140234332 Novel hiv-2 isolate |
08/21/2014 | US20140234331 Human ctla-4 antibodies and their uses |
08/21/2014 | US20140234330 Il-17 receptor a is required for il-17c biology |
08/21/2014 | US20140234329 Antibodies against the ectodomain of erbb3 and uses thereof |
08/21/2014 | US20140234328 Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients |
08/21/2014 | US20140234327 Monoclonal antibody against human non-small cell lung carcinoma and use thereof |
08/21/2014 | US20140234326 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer |
08/21/2014 | US20140234325 Adjuvant therapy for staphylococcal infection with enterotoxin specific mabs |
08/21/2014 | US20140234324 Methods for treating a tumor using an antibody that specifically binds grp94 |
08/21/2014 | US20140234323 Compositions and methods for detecting tlr3 |